We are very pleased to announce that Evan Castiglia has joined the Thuja team as of April 1st, as an investment director and partner.
Prior to joining Thuja, he was Partner and Head of European Investments for Philips Ventures, the corporate venture capital group of Philips. During his tenure, Evan led and managed numerous investments across healthcare sectors, including medical device and digital health, and across investment stages from early to growth. Before joining Philips Ventures, Evan was the Chief Business Officer of the U.S.-based venture backed precision biology company, RareCyte, which he helped lead from product concept to international commercialization. Evan holds an M.B.A with Distinction from the University of Oxford.
We cordially welcome Evan and look forward to working with him to select and build many impactful healthcare ventures.